1. Evans MJ, Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292(5819): 154-156.
2. Martin GR. Isolation of pluripotent cell line from early mouse embryos in medium conditioned by terato­carcinoma stem cells. Proc Natl Acad Sci USA 1981; 78(12): 7634-7638.
3. Stevens LC. Testicular, ovarian and embryo-derived teratomas. Cancer Sur 1980; 2(1): 75-91.
4. Martin GR. Teratocarcinoma and mammalian em­bryogenesis. Science 1980; 209(4458): 768-776.
5. Pera MF, Reubinoff B, Trounson A. Human embryonic stem cells. J Cell Sci 2000; 113(1): 5-10.
6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-1147.
7. Nassiri R. Stem cells – a new frontier in 21st century medicine. Med Sci Monit 2001; 7(6): 1121-1122.
8. Robertson JA. Human embryonic stem cell re­search: ethical and legal issues. Nat Rev Genet 2001; 2(1): 74-78.
9. Wobus AM. Potential of embryonic stem cells. Mol Asp Med 2001; 22(3): 149-164.
10. McKay R. Stem cells in the central nervous system. Science 1997; 276(5309): 66-71.
11. Gage FH. Mammalian neural stem cells. Science 2000; 287(5457): 1433-1438.
12. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893): 41-49.
13. Bjornson CRR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hemato­poietic fate adopted by adult neural stem cells in vivo. Science 1999; 283(5401): 534-537.
14. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113(5): 631-642.
15. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122(6): 947-956.
16. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113(5): 643-655.
17. Hamazaki T, Oka M, Yamanaka S, Terada N. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 2004; 117(23): 5681-5686.
18. Lang D, Lu MM, Huang L, Engleka KA, Zhang M, Chu EY, Lipner S, Skoultchi A, Millar SE, Epstein JA. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 2005; 433(7028): 884-887.
19. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui SI, Carpenter M, Gazdar AF, Rao M, Chakravarti A. Genom­ic alterations in cultured human embryonic stem cells. Nat Genet 2005; 37(10?): 1099-1103.
20. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myicardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7(4): 430-436.
21. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361(9351): 45-46.
22. Gehling UM, Ergun S, Schumacher U, Wafener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95(10): 3106-3112.
23. Shi Q, Rafii S, Wu MH-D, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore M, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92(2): 362-367.
24. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moor MAS, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000; 95(3): 952-958.
25. Quirici N, Soligo D, Caneva L, Servida F, Bosso­lasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol 2001; 115(1?): 186-194.
26. Burns CJ, Persaud SJ, Jones PM. Stem cell therapy for diabetes: do we need to make b cells? J Endo­crinol 2004; 183(3): 437-443.
27. RamiyaVK, Maraist M, Arfors KE, Schats DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000; 6(3): 278-282.
28. Horb M, Shen CN, Tosh D, Slack JMW. Experimental conversion of liver to pancreas. Curr Biol 2003; 13(2): 105-115.
29. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111(6): 843-850.
30. Arenas E. Stem cells in the treatment of Parkinson’s disease. Brain Res Bull 2002; 57(6): 795-808.
31. Langstone JW. The promise of stem cells in Parkinson’s disease. J Clin Invest 2005; 115(1): 23-25.
32. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97(26): 14720-14725.
33. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432(7015): 324-331.
34. Trichopoulos D, Lagiou P, Adami HO. Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Nature 2004; 432(7015): 396-401.
35. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumor initiating cells. Nature 2004; 432(7015): 281-282.
36. Gil J, Bernard D, Peters G. Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol 2005; 24(2): 117-125.
37. Xu Y. A new role of p53 in maintaining genetic stability in embryonic stem cells. Cell Cycle 2005; 4(3): 363-364.
38. Secko D. Do stem cells cause gastric cancer? Canad Med Assoc J 2005; 172(3): 325-326.
39. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005; 19(10): 1129-1155.
40. Li M, Pevny L, Lovell-Badge R, Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 1998; 8(17): 971-974.
41. Billon N, Jolicoeur C, Ying QL, Smith A, Raff M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cell Sci 2002; 115(18): 3657-3665.
42. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. The new stem cell biology: something for everyone. J Clin Pathol 2003; 56(2):86-96.